Defective co-activator recruitment in osteoclasts from microphthalmia-oak ridge mutant mice

Sudarshana M Sharma1, Said Sif, Michael C Ostrowski

  • 1Department of Molecular and Cellular Biochemistry, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.

Insights

The microphthalmia-associated transcription factor (Mitf) mutation Mitf(or/or) impairs osteoclast function by reducing Cathepsin K expression. This defect in osteoclast differentiation is linked to impaired co-activator recruitment to the Cathepsin K gene promoter.

Area of Science:

  • Molecular Biology
  • Genetics
  • Developmental Biology

Background:

  • The microphthalmia-associated transcription factor (Mitf) is crucial for melanocyte development and affects osteoclast differentiation.
  • Specific DNA-binding domain mutations in Mitf, including Mitf(mi/mi), Mitf(or/or), and Mitf(wh/wh), impact osteoclast differentiation and melanocyte development with varying severity.
  • Mitf(or/or) mice display osteopetrosis, a condition characterized by impaired bone resorption, despite forming multinuclear osteoclasts, prompting investigation into the underlying molecular mechanisms.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which the Mitf(or/or) mutation leads to osteopetrosis.
  • To investigate the expression levels of key osteoclast-specific genes, such as Acp5 and Ctsk, in Mitf(or/or) osteoclasts.
  • To determine the role of Mitf protein recruitment and co-activator binding at the Ctsk promoter in the context of the Mitf(or/or) mutation.

Main Methods:

  • Comparative analysis of gene expression (mRNA levels) for Acp5 and Ctsk in wild-type and Mitf(or/or) osteoclasts during RANKL-mediated differentiation.
  • Chromatin immunoprecipitation (ChIP) assays to assess the recruitment of Mitf(or/or) protein and co-activators (PU.1, Brg1) to the Ctsk promoter.
  • Assessment of osteoclast differentiation and function in Mitf mutant mouse models.

Main Results:

  • Mitf(or/or) osteoclasts exhibited normal Acp5 mRNA levels but significantly reduced Ctsk mRNA levels compared to wild-type.
  • ChIP analysis revealed reduced recruitment of the mutant Mitf(or/or) protein to the Ctsk promoter.
  • Crucially, the enrichment of Mitf-transcriptional co-activators PU.1 and Brg1 at the Ctsk promoter was severely impaired in Mitf(or/or) osteoclast precursors.

Conclusions:

  • The Mitf(or/or) mutation impairs osteoclast function primarily through the downregulation of Cathepsin K (Ctsk) expression.
  • Defective recruitment of essential co-activators, PU.1 and Brg1, by the mutant Mitf(or/or) protein at the Ctsk promoter is the underlying cause of reduced Ctsk expression.
  • Cathepsin K represents a critical osteoclast-specific gene regulated by Mitf, essential for proper osteoclast function.